Adalimumab treatment may replace or enhance the activity of steroids in steroid-refractory tuberculous meningitis

• LEE Ho-Su

  Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine

• LEE Yumi

  Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine

• LEE Sang-Oh

  Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine

• CHOI Sang-Ho

  Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine

• KIM Yang Soo

  Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine

• WOO Jun Hee

  Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine

• KIM Sung-Han

  Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine

Journal

• Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 18 (4), 555-557, 2012-08-01

Keywords

• Tuberculosis
• Paradoxical reaction
• Steroid-refractory
• Tumor necrosis factor inhibitor
• Adalimumab

Details

• CRID: 1572543025652174720
• NII Article ID: 10030948227
• NII Book ID: AA11057978
• ISSN: 1341321X
• Web Site: https://search.jamas.or.jp/link/ui/2013323911
• Text Lang: en
• Data Source:
  • CiNii Articles